SLRX
Salarius Pharmaceuticals Inc
NASDAQ: SLRX · HEALTHCARE · BIOTECHNOLOGY
$0.84
+29.23% today
Updated 2026-01-07
Market cap
$4.92M
P/E ratio
—
P/S ratio
18.12x
EPS (TTM)
$-24.24
Dividend yield
—
52W range
$1 – $25
Volume
2.4M
Salarius Pharmaceuticals Inc (SLRX) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $1.01M | $1.27M | $838000.00 | $3.47M | $5.23M | $1.84M | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | +26.1% | -34.3% | +313.5% | +51.0% | -64.8% | -100.0% | — | — |
| Cost of revenue | $11997.00 | $49881.00 | $663000.00 | $507000.00 | $431000.00 | $4018.00 | $6913.00 | $19183.00 | $6677.00 | $10051.00 | $4424.00 |
| Gross profit | $-11997.00 | $-49881.00 | $348000.00 | $768000.00 | $407000.00 | $3.47M | $5.23M | $1.82M | $-6677.00 | $-10051.00 | $-4424.00 |
| Gross margin | — | — | 34.4% | 60.2% | 48.6% | 100.0% | 100.0% | 99.0% | — | — | — |
| R&D | $4.00M | $12.75M | $20.38M | $16.99M | $11.91M | $4.02M | $6.91M | $8.55M | $15.84M | $7.17M | $770027.00 |
| SG&A | — | $16.46M | $19.86M | $18.50M | $10.57M | $7.71M | $6.11M | $6.10M | $7.14M | $5.72M | $4.96M |
| Operating income | $-8.03M | $-29.21M | $-39.89M | $-34.73M | $-22.07M | $-8.27M | $-7.79M | $-12.81M | $-31.84M | $-12.89M | $-5.73M |
| Operating margin | — | — | -3945.2% | -2723.6% | -2634.1% | -238.5% | -148.8% | -696.3% | — | — | — |
| EBITDA | $-8.00M | $-29.16M | $-39.61M | $-34.40M | $-21.85M | $-8.14M | $-7.59M | $-12.79M | $-22.97M | $-12.88M | $-5.73M |
| EBITDA margin | — | — | -3917.8% | -2698.2% | -2606.9% | -234.8% | -145.1% | -695.2% | — | — | — |
| EBIT | $-8.01M | $-29.21M | $-39.89M | $-34.73M | $-22.07M | $-8.26M | $-7.61M | $-12.81M | $-22.98M | $-12.89M | $-5.73M |
| Interest expense | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $3047.00 | $44693.00 | $233184.00 | — | — |
| Income tax | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-8.01M | $-29.14M | $-39.49M | $-34.43M | $-21.92M | $-6.94M | $-7.35M | $-12.77M | $-31.61M | $-12.54M | $-5.58M |
| Net income growth (YoY) | — | -263.8% | -35.5% | +12.8% | +36.3% | +68.4% | -6.0% | -73.7% | -147.6% | +60.3% | +55.5% |
| Profit margin | — | — | -3906.3% | -2700.7% | -2616.0% | -200.2% | -140.5% | -693.8% | — | — | — |